Transfuzní přípravky a krevní deriváty ve světle nových evropských doporučení při život ohrožujícím krvácení

Title in English Transfusion products and blood derivatives in light of new European guidelines for severe bleeding
Authors

VRBICA Kamil VANÍČKOVÁ Kateřina PROKOPOVÁ Tereza KELLER Filip HUDEC Jan HRDÝ Ondřej JENDRICHOVSKÝ Jakub GÁL Roman

Year of publication 2024
Type Article in Periodical
Magazine / Source Transfuze a hematologie dnes
MU Faculty or unit

Faculty of Medicine

Citation
web https://redakce.carecomm.cz/tahd/article/view/2343
Doi http://dx.doi.org/10.48095/cctahd2024prolekare.cz18
Keywords bleeding; guidelines; blood transfusion; blood coagulation factors
Description Major bleeding is one of the most serious emergencies in medicine. This situation requires a complex therapeutic approach, including standardised administering transfusion products and blood derivatives. In the Czech Republic and Slovakia, the document “Diagnosis and Treatment of Life-Threatening Bleeding in Adult Patients in Intensive and Perioperative Care. Czech-Slovak Interdisciplinary Guideline” from 2017 remains valid. In 2023, an update of both European guidelines, from which the mentioned interdisciplinary procedure predominantly derives, was published. This work aims to identify and present changes in the European guidelines for severe bleeding since 2017. A total of 4 texts are included. Their analysis was divided according to individual transfusion products and blood derivatives. This work not only presents the new European guidelines for treating severe bleeding, but also compares these with the Czech-Slovak guideline from 2017.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info